LBPH Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.

$4.37
As of 05/23/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/12/2021
Outstanding shares:  13,585,950
Average volume:  4,654
Market cap:   $59,370,602
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.80
PS ratio:   0.00
Return on equity:   -54.03%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy